Visivra Official Website › Label & Amounts
Label & AmountsVisivra Label And Amounts: The Panel, Transcribed
The Visivra front panel prints four lines and no quantities.
Wordmark, 30 Capsules, DIETARY SUPPLEMENT, an eye glyph. The vendor's own ingredient graphic adds six names and no figures, and the seller's page agrees. This page transcribes what is there and prints the amount each of the six was tested at beside it.
One page, in the place where the awkward part belongs, so the rest of this site can get on with describing the bottle.
Everything printed on the Visivra front panel
Read it as a transcription. Every claim this site makes about the label comes off this face.
Four lines, and this is all of them:
- VisiVra
- 30 Capsules
- DIETARY SUPPLEMENT
- A line-drawn eye, in the label's azure
The panel is a white cylinder with an azure gradient running up from the base, the wordmark set in two tones across the middle, the capsule count in a rounded box beneath it, DIETARY SUPPLEMENT under that in small caps, and a line-drawn eye at the foot. There is no ingredient list on this face, no serving size, no percent Daily Value and no directions line, because those belong on the back of a bottle and no back-label render ships with this pack.
That is a statement about the artwork supplied, not an accusation about the physical bottle. A real bottle sold in the United States carries a Supplement Facts panel by law. What this desk can say is what it can see, and what it can see is the front.
The three Visivra sources that all say the same thing
| Source | What it gives | Amounts |
|---|---|---|
| The front panel artwork | Brand, count, DIETARY SUPPLEMENT, an eye glyph | None |
| The vendor's INSIDE VISIVRA graphic | Six framed photographs with six names, and a footer strip reading 30 CAPSULES, SIX NAMED INGREDIENTS, DIETARY SUPPLEMENT | None |
| The seller's own product page, read 19 September 2026 | The same six names, in a paragraph about the formula | None |
Three independent sources, six names, zero figures. That agreement is why this site carries no supplement-facts page: a page about a panel needs a panel.
It is worth saying plainly what this desk will not do. It will not reconstruct likely amounts from a competitor's label, it will not quote an AREDS2 figure as though it were this bottle's, and it will not treat the absence of a number as evidence that the number is small. Any of those would be more useful to read and none of them would be true.
The Visivra label beside the trials, in full
The right-hand column is the useful half of this page. Every figure in it was read out of the abstract of the trial it belongs to, and the record each came from is named in the reference list at the foot. Read the table as: here is what was tested, and here is what the bottle tells you.
The rows are not equivalent in weight. Lutein and zeaxanthin have a five-year trial behind them at a specific pair of amounts. Bilberry has three small trials at three different amounts. Astaxanthin has one, in children. Zinc has a formula behind it rather than an ingredient, and it was paired with copper deliberately. Vitamin A has no eye-supplement trial amount at all, only an upper limit and a reason to ask about form.
Why a Visivra amount would change what this site could say
It is worth being concrete about what a printed panel would buy a reader, because the answer is more than tidiness.
With a lutein figure, a buyer could compare this bottle against the AREDS2 amount and decide whether it is in the same territory or a tenth of it. With a zinc figure, they could add it to whatever else they take and check it against an upper limit. With a vitamin A form and figure, a smoker could make an informed decision in thirty seconds instead of telephoning. With a bilberry figure, they could see whether it sits near the 240 mg that moved ciliary muscle tone or well below it.
None of those four questions can be answered from this artwork. They can all be answered by the order desk, which is why the contact page lists them as the four things worth calling about.
A photograph of the back label, or the Supplement Facts panel as a text file. If either arrives, the table above gains a real left-hand column, this page gets rewritten around it, and the review date at the foot moves. Until then the column stays empty rather than estimated.
What the Visivra artwork does carry besides the panel
Ten marks ship with this pack and a payment-card row. None of them is a quantity, and each is audited one by one on the testing and quality page rather than displayed here as proof.
The only fine print on the artwork is the federal line: “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.” There is no consult-a-clinician caution printed anywhere on this front panel, which is unusual for the category and is stated here once rather than invented.
The pack's written paperwork mentions none of these marks. They are on the artwork and nowhere else in what the supplier sent.
Who publishes this Visivra website?
- Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-15. PMID 23644932. https://pubmed.ncbi.nlm.nih.gov/23644932/
- Kosehira M, Machida N, Kitaichi N. A 12-Week-Long Intake of Bilberry Extract (Vaccinium myrtillus L.) Improved Objective Findings of Ciliary Muscle Contraction of the Eye: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial. Nutrients. 2020;12(3). PMID 32106548. https://pubmed.ncbi.nlm.nih.gov/32106548/
- Ozawa Y, Kawashima M, Inoue S, et al. Bilberry extract supplementation for preventing eye fatigue in video display terminal workers. J Nutr Health Aging. 2015;19(5):548-54. PMID 25923485. https://pubmed.ncbi.nlm.nih.gov/25923485/
- Kamiya K, Kobashi H, Fujiwara K, et al. Effect of fermented bilberry extracts on visual outcomes in eyes with myopia: a prospective, randomized, placebo-controlled study. J Ocul Pharmacol Ther. 2013;29(3):356-9. PMID 23113643. https://pubmed.ncbi.nlm.nih.gov/23113643/
- Hecht KA, Marwah M, Wood V, et al. Astaxanthin (AstaReal) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial. Adv Ther. 2025;42(4):1811-1833. PMID 40014233. https://pubmed.ncbi.nlm.nih.gov/40014233/
- Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-36. PMID 11594942. https://pubmed.ncbi.nlm.nih.gov/11594942/
- Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150-5. PMID 8602180. https://pubmed.ncbi.nlm.nih.gov/8602180/
- The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029-35. PMID 8127329. https://pubmed.ncbi.nlm.nih.gov/8127329/
- Institute of Medicine (US) Panel on Micronutrients. Zinc. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001. https://www.ncbi.nlm.nih.gov/books/NBK222317/
- Institute of Medicine (US) Panel on Micronutrients. Vitamin A. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001. https://www.ncbi.nlm.nih.gov/books/NBK222318/
Order Visivra with the label question answered
Call the order desk first if the amount matters to you. It is a two-minute conversation and it is the one this page cannot have on your behalf.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order Visivra On The Official WebsiteOne capsule a day · 30 per bottle · lot VIS-26/VI-5716